Coronavirus: a clinical update of Covid-19

Mateus da Silveira Cespedes1, José Carlos Rosa Pires de Souza2

  • 1. Acadêmico de medicina da Universidade Estadual de Mato Grosso do Sul, Dourados, MS, Brasil.

Revista Da Associacao Medica Brasileira (1992)
|May 20, 2020
PubMed

Insights

The COVID-19 pandemic, caused by SARS-CoV-2, presents mild to severe symptoms and spreads similarly to H1N1 but with lower mortality. Early detection and supportive care are key, with potential treatments like hydroxychloroquine and azithromycin for severe cases.

Area of Science:

  • Virology
  • Epidemiology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic, declared by the WHO, has increased global awareness of the SARS-CoV-2 virus.
  • The virus affects individuals with comorbidities and advanced age, with transmissibility similar to H1N1 but lower mortality rates.
  • SARS-CoV-2 invades cells via angiotensin-converting enzyme 2, affecting the respiratory and intestinal mucosa.

Purpose of the Study:

  • To summarize the key aspects of the COVID-19 pandemic, including its epidemiology, viral characteristics, clinical presentation, and management strategies.
  • To highlight the diagnostic capabilities and potential therapeutic interventions for COVID-19.

Main Methods:

  • Review of epidemiological data on COVID-19 spread and transmissibility.
  • Description of the SARS-CoV-2 virus's cellular invasion mechanism.
  • Categorization of clinical presentations into mild and severe forms.
  • Discussion of diagnostic methods like CRP-TR for viral load detection.
  • Overview of supportive care, infection control, and potential pharmacological treatments.

Main Results:

  • COVID-19 has spread globally, affecting a significant number of patients.
  • Clinical presentation ranges from mild symptoms (fever, cough) to severe respiratory distress (hypoxemia, dyspnea).
  • A 2% mortality rate is estimated, with supportive care and infection control as primary management.

Conclusions:

  • Early detection of viral load using CRP-TR is crucial for patients with high clinical suspicion.
  • Supportive measures and infection control are the cornerstones of COVID-19 management.
  • While hydroxychloroquine and azithromycin show promise for severe cases, corticosteroids should be avoided. ACEIs/ARBs use is unrestricted.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
696
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
634
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.3K